Fig. 1 · Structure
Documents & Downloads
Myristoleic acid
Necrosis Activator
Myristoleic acid is a necrosis activator that exhibits cytotoxic effects by inducing apoptosis and necrosis in human prostate cancer LNCaP cells. This compound can be utilized in research related to cancer therapeutics and the exploration of apoptotic pathways. Its ability to modulate cellular functions makes it a valuable tool for studying prostate cancer mechanisms and potential treatment strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Activator |
| CAS Number | 544-64-9 |
| Applications | Necrosis Activator |
| Formula | C14H26O2 |
| Molecular Weight | 226.36 |
| SMILES | CCCC/C=C\CCCCCCCC(O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.